公司資料
Merit Medical 股價、新聞與催化劑
- 股票代碼:
- MMSI
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
89.73 USD (-1.13%)
收盤價
最後更新: 2026年8月17日
3.63B USD
市值
股價為何變動
As of Aug 17, 2026, MMSI closed down 1.13% at $89.73. No new same-company headline was identified in the current news window.
公司概覽
Diversified Interventional MedTech Company
Merit Medical is a global manufacturer and marketer of healthcare technology, with a broad product portfolio used across interventional and procedural medicine. Its business is driven by recurring device demand, product category breadth, international distribution, and execution in hospital and outpatient settings.
Broad Product Category Exposure
The company sells into multiple medical device categories rather than relying on one franchise. Its second-quarter results highlighted improving growth trends across the global business, with particular strength in the U.S. market. This diversified structure gives Merit exposure to several procedure-driven revenue streams and reduces dependence on a single product launch.
Margin and Operating Discipline
Merit is executing against its Continued Growth Initiative, with emphasis on organic revenue growth, profitability improvement, and cash generation. In the second quarter of 2026, the company expanded both GAAP and non-GAAP margins while delivering 9% organic constant-currency revenue growth.
Strategic Position
Merit is best understood as a scaled, diversified interventional device company. Its differentiation comes from breadth, procedure exposure, and operational discipline rather than a single breakthrough technology. Near-term performance depends on maintaining organic growth, improving profitability, and converting strategic planning into sustainable long-term expansion.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。